ArticleThe Korean journal of hematology2010

Bortezomib and melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma.

Se Ryeon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.